These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 77812)

  • 1. Coumarin-induced abnormal factor IX: an immunological study in humans.
    Girolami A; Sticchi A; Burul A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1978; 105(1):117-24. PubMed ID: 77812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factor IX antigen by radioimmunoassay. Abnormal factor IX protein in patients on warfarin therapy and with hemophilia B.
    Thompson AR
    J Clin Invest; 1977 May; 59(5):900-10. PubMed ID: 856873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laser nephelometer evaluation of factor IX.
    Ruzza G; Lazzaro AR; Viero ML; Girolami A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(6):843-9. PubMed ID: 1713891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization and experimental use of a monospecific antiserum to factor IX.
    Pechet L; Tiarks CY; Chang CH; Sudhindra RR; Lipworth L
    Thromb Haemost; 1979 Feb; 40(3):455-64. PubMed ID: 106483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The abnormal factor IX of hemophilia B+ variants.
    Bertina RM; Veltkamp JJ
    Thromb Haemost; 1978 Oct; 40(2):335-49. PubMed ID: 734633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electroimmunoassay of factor IX in patients with liver damage and vitamin K unresponsive coagulation disorder.
    Girolami A; Burul A; Cappellato G; Dal Bo Zanon R
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1979; 106(1):65-71. PubMed ID: 88391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An immunological method for detection of the carrier of hemophilia B.
    Matsuoka M; Ito M; Takahashi K; Sakuragawa N
    Thromb Haemost; 1976 Nov; 36(2):441-50. PubMed ID: 1036844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunological heterogeneity of haemophilia B: a multicentre study of 98 kindreds.
    Parekh VR; Mannucci PM; Ruggeri ZM
    Br J Haematol; 1978 Dec; 40(4):643-55. PubMed ID: 103564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Excess of factor X antigen versus clotting counterpart in coumarin treated patients as determined by an Elisa method.
    Girolami A; Vicarioto MA; Ruzza G; Vergolani A; Boeri G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(2):326-32. PubMed ID: 2410342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure and function of factor IX: defects in haemophilia B.
    McGraw RA; Davis LM; Lundblad RL; Stafford DW; Roberts HR
    Clin Haematol; 1985 Jun; 14(2):359-83. PubMed ID: 3899439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alloantibodies to factor IX in Haemophilia B characterized by crossed immunoelectrophoresis and enzyme-conjugated antisera to human immunoglobulins.
    Orstavik KH
    Br J Haematol; 1981 May; 48(1):15-23. PubMed ID: 6788066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-natal development of factor IX.
    Schettini F; De Mattia D; Altomare M; Montagna O
    Acta Paediatr Scand; 1980 Jan; 69(1):53-8. PubMed ID: 7368912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purification and properties of an abnormal blood coagulation factor IX (factor IXBm)/kinetics of its inhibition of factor X activation by factor VII and bovine tissue factor.
    Osterud B; Kasper CK; Lavine KK; Prodanos C; Rapaport SI
    Thromb Haemost; 1981 Feb; 45(1):55-9. PubMed ID: 7245126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunological studies on factor IX antigen in patients with hemophilia B variant].
    Fujimura Y; Takase T; Sakai T; Shima M; Fukui H
    Nihon Ketsueki Gakkai Zasshi; 1982 Sep; 45(5):952-61. PubMed ID: 7158257
    [No Abstract]   [Full Text] [Related]  

  • 15. Factor VII activity and antigen in haemophilia B variants.
    Mazzucconi MG; Bertina RM; Romoli D; Orlando M; Avvisati G; Mariani G
    Thromb Haemost; 1980 Feb; 43(1):16-9. PubMed ID: 7404475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of carriers of haemophilia B.
    Orstavik KH; Veltkamp JJ; Bertina RM; Hermans J
    Br J Haematol; 1979 Jun; 42(2):293-301. PubMed ID: 465373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitive solid phase enzyme immunoassay for factor IX antigen and classification of hemophilia B.
    Takamatsu J; Kamiya T; Ogata K; Sugihara T; Koie K; Kato K
    Haemostasis; 1983; 13(1):9-16. PubMed ID: 6341181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rabbit polyclonal antibodies against the calcium-dependent conformation of factor IX and their application in solid phase immunoradiometric assays.
    Poort SR; van der Linden IK; Krommenhoek-van Es C; Briët E; Bertina RM
    Thromb Haemost; 1986 Feb; 55(1):122-8. PubMed ID: 3704999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcium-specific immunoassays for factor IX: reduced levels of antigen in patients with vitamin K disorders.
    Bray GL; Weinmann AF; Thompson AR
    J Lab Clin Med; 1986 Mar; 107(3):269-78. PubMed ID: 3485164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factor IX alloantibodies shorten the bovine thromboplastin coagulation time of normal human plasma.
    Orstavik KH
    Thromb Haemost; 1981 Dec; 46(4):684-6. PubMed ID: 7330818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.